107 related articles for article (PubMed ID: 3437420)
1. Plasma glycosaminoglycans in systemic lupus erythematosus.
Friman C; Nordström D; Eronen I
J Rheumatol; 1987 Dec; 14(6):1132-4. PubMed ID: 3437420
[TBL] [Abstract][Full Text] [Related]
2. The urinary excretion of glycosaminoglycans and heparan sulphate in lupus nephritis.
Parildar Z; Uslu R; Tanyalcin T; Doganavsargil E; Kutay F
Clin Rheumatol; 2002 Aug; 21(4):284-8. PubMed ID: 12189454
[TBL] [Abstract][Full Text] [Related]
3. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
4. [Serum level of beta-glucuronidase as potential indicator of disease activity in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE)].
Falkenbach A; Unkelbach U; Gottschalk R; Kaltwasser JP
Med Klin (Munich); 1991 Sep; 86(9):465-8. PubMed ID: 1943985
[TBL] [Abstract][Full Text] [Related]
5. Cortisol catabolism by lymphocytes of patients with systemic lupus erythematosus and rheumatoid arthritis.
Klein A; Buskila D; Gladman D; Bruser B; Malkin A
J Rheumatol; 1990 Jan; 17(1):30-3. PubMed ID: 2313669
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
Her M; Kim D; Oh M; Jeong H; Choi I
Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
[TBL] [Abstract][Full Text] [Related]
7. Acid glycosaminoglycans in plasma. II. Findings in rheumatoid arthritis.
Friman C; Juvani M; Skrifvars B
Scand J Rheumatol; 1977; 6(3):177-82. PubMed ID: 929124
[TBL] [Abstract][Full Text] [Related]
8. Urinary glycosaminoglycan composition in chronic glomerulonephritis.
De Muro P; Faedda R; Satta A; Finetti D; Masala A; Cigni A; Sanna GM; Cherchi GM
J Nephrol; 2005; 18(2):154-60. PubMed ID: 15931643
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
Vogl D; Falk W; Dorner M; Schölmerich J; Straub RH
J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
[TBL] [Abstract][Full Text] [Related]
11. Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus.
Straub RH; Weidler C; Demmel B; Herrmann M; Kees F; Schmidt M; Schölmerich J; Schedel J
Ann Rheum Dis; 2004 Aug; 63(8):961-8. PubMed ID: 15249323
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
13. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
Lub-de Hooge MN; de Vries EG; de Jong S; Bijl M
Ann Rheum Dis; 2005 Jun; 64(6):854-8. PubMed ID: 15564310
[TBL] [Abstract][Full Text] [Related]
14. Increased excretions of glycosaminoglycans and heparan sulfate in lupus nephritis and rheumatoid arthritis.
Biçer I; Aksu K; Parildar Z; Tanyalçin T; Doğanavşargil E; Kutay FZ
Rheumatol Int; 2003 Sep; 23(5):221-5. PubMed ID: 14504913
[TBL] [Abstract][Full Text] [Related]
15. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
[TBL] [Abstract][Full Text] [Related]
16. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis.
Härle P; Pongratz G; Weidler C; Büttner R; Schölmerich J; Straub RH
Ann Rheum Dis; 2004 Jul; 63(7):809-16. PubMed ID: 15194576
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus.
Rosenau BJ; Schur PH
J Rheumatol; 2009 Apr; 36(4):753-6. PubMed ID: 19273453
[TBL] [Abstract][Full Text] [Related]
18. [Electrophoretic and enzymatic analysis of glycosaminoglycans in the blood serum of patients with hyperthyroidism].
Wład H; Lacka K
Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):746-8. PubMed ID: 2641799
[TBL] [Abstract][Full Text] [Related]
19. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
[TBL] [Abstract][Full Text] [Related]
20. [The level of the tumor necrosis factor in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
Prokop'ev AA; Alekseeva TG; Zimina ZV; Ketlinskiĭ SA
Ter Arkh; 1993; 65(5):9-12. PubMed ID: 8036608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
